Technical Analysis for PDLI - PDL BioPharma, Inc.

Grade Last Price % Change Price Change
grade A 3.39 0.89% 0.03
PDLI closed up 0.89 percent on Wednesday, February 26, 2020, on 1.33 times normal volume. It was able to find support at its 50 day moving average. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
Earnings due: Mar 12
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical PDLI trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
50 DMA Support Bullish 0.89%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.89%
Fell Below 20 DMA Bearish -1.31%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.31%
MACD Bearish Signal Line Cross Bearish -2.59%
20 DMA Support Bullish -2.59%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases, as well as other medical conditions. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
Biotechnology Cancer Life Sciences Antibodies Monoclonal Antibodies Antibody Humanized Antibody

Is PDLI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.89
52 Week Low 2.06
Average Volume 1,268,322
200-Day Moving Average 2.93
50-Day Moving Average 3.35
20-Day Moving Average 3.48
10-Day Moving Average 3.55
Average True Range 0.13
ADX 23.21
+DI 21.31
-DI 24.36
Chandelier Exit (Long, 3 ATRs ) 3.46
Chandelier Exit (Short, 3 ATRs ) 3.55
Upper Bollinger Band 3.75
Lower Bollinger Band 3.22
Percent B (%b) 0.32
BandWidth 15.18
MACD Line 0.04
MACD Signal Line 0.07
MACD Histogram -0.0317
Fundamentals Value
Market Cap 522.33 Million
Num Shares 154 Million
EPS 0.44
Price-to-Earnings (P/E) Ratio 7.70
Price-to-Sales 3.18
Price-to-Book 0.56
PEG Ratio 0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.57
Resistance 3 (R3) 3.55 3.47 3.54
Resistance 2 (R2) 3.47 3.42 3.48 3.53
Resistance 1 (R1) 3.43 3.40 3.45 3.45 3.52
Pivot Point 3.35 3.35 3.36 3.36 3.35
Support 1 (S1) 3.31 3.30 3.33 3.33 3.26
Support 2 (S2) 3.23 3.28 3.24 3.25
Support 3 (S3) 3.19 3.23 3.24
Support 4 (S4) 3.21